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Ischemic stroke is a major cause of morbidity and mor-
tality in the elderly. Although several vascular risk
factors [1,2], such as hypertension, diabetes mellitus,
cigarette smoking and alcohol consumption, have been
established, the role of other putative risk factors like
hypercholesterolemia still needs to be elucidated. On
the other hand, the types of ischemic stroke seem to dif-
fer between Western and Asian countries, and Asians
have been found to have more intracranial athero-
sclerosis than Caucasians [3–7]. In the Western popu-
lation, a positive association between cholesterol levels
and ischemic stroke has been noted [8], whereas in
studies on Asians, an inverse relationship between
cholesterol levels and the occurrence of stroke has been
observed [3,9].
Apolipoprotein E (APOE; NM_000041) is an im-
portant regulator of the metabolism of cholesterol
and other lipids [10]. APOE has three major isoforms,
APOE2, E3, and E4, which are encoded by three alleles
(epsilon 2, 3, and 4) at a gene located on the long arm
of chromosome 19. The E2 (MIM 107741.0001), E3
(MIM 107741.0015) and E4 (MIM 107741.0016) iso-
forms differ in amino acid sequence at two sites: re-
sidue 112 (called site A) and residue 158 (called site B).
At sites A/B, APOE2, E3 and E4 contain cysteine/
cysteine, cysteine/arginine and arginine/arginine,
respectively. ε4 has been found to be associated with
higher plasma cholesterol levels and ε2 with lower
plasma cholesterol levels [11]. However, the associa-
tion of APOE with stroke has been controversial
[1,2,9,12–19], possibly due to inaccurate classifications
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The aim of this study was to clarify whether the apolipoprotein E gene (APOE) is related to
ischemic stroke subtypes in Taiwan’s Chinese population. Using the classification of Cerebrovas-
cular Diseases III, 143 patients with lacunar infarction, 114 patients with atherothrombotic infarc-
tion, and 112 healthy controls were enrolled. APOE genotype was determined using polymerase
chain reaction. Regarding the distribution of APOE genotypes, the frequency of ε3/ε4 genotypes
in lacunar patients was significantly different from that in control subjects, by logistic regression,
using ε3/ε3 as a reference group. There was no significant difference between atherothrombotic
patients and the control group in the distribution of APOE genotypes or alleles. The present find-
ing suggests that there is a probable association between ε3/ε4 genotype and lacunar infarcts, but
not atherothrombotic infarcts. This indicates that genetic factors may play a role, at least partially,
in lacunar infarction in Taiwan’s Chinese population.
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of stroke or small sample sizes. On the other hand,
the distributions of APOE alleles have been found to
have wide variations among different populations
[20–29]. For example, studies have shown that the
frequency of the APOE ε4 allele ranges from 9.0% to
16.5% in Western populations and from 4.9% to 11.0%
in Chinese [22–24,26,28,29]. Whether the difference in
the APOE polymorphism between races is an inde-
pendent predictor of intracranial atherosclerotic stroke
or whether it is confounded by the prevalence of var-
ious stroke risk factors has not been clearly determined.
Thus, the aim of this study was to clarify the associa-
tion of the APOE polymorphism with ischemic stroke
subtypes in Taiwan Chinese.
PATIENTS AND METHODS
The present case-control study was conducted in
Kaohsiung Medical University Hospital (KMUH),
Taiwan, from January 1996 to December 1997. Patients
with rheumatic heart disease, epidural hematoma,
brain tumor, or accidental or iatrogenic stroke were
excluded from the study. Of the 406 consecutive pa-
tients with ischemic stroke and neurologic symptoms
lasting more than 24 hours, accompanied by corre-
sponding focal density changes detected by magnetic
resonance imaging during the study period, 326
(80.4%) were examined at the neurologic outpatient
clinic 3 months after the stroke. The remaining 80
patients were not enrolled in the present study (includ-
ing 53 who had moved, lost contact, or refused follow-
up evaluation, 12 who had incomplete data collection,
10 who had died prior to the first follow-up and 
5 who lived in long-term care institutions). Of the 326
patients, 49 cases with probable vascular dementia
according to the National Institute of Neurological
Disorders and Stroke and the Association International
pour la Recherche et l’Enseignement en Neurosciences
(NINDS-AIREN) clinical criteria were excluded to
avoid classification confusion with mixed-type demen-
tia. Ischemic stroke was classified as lacunar infarc-
tion and atherothrombotic infarction according to the
Classification of Cerebrovascular Diseases III [30].
Under this classification, 20 cases that belonged to
the category of ischemic stroke with cardioembolism
or other types were also excluded. Finally, 143 cases
were defined as having lacunar infarcts and 114 cases
as having atherothrombotic infarcts.
Control subjects (n = 112) were healthy elderly vol-
unteers who underwent a regular health examination
in KMUH in 1996. Each healthy control subject was
interviewed and examined by a neurologist to rule
out stroke and cognitive deficits clinically. There were
no relations of kinship among the controls and/or
stroke patients.
Genomic DNA was extracted from peripheral blood
leukocytes using a QIAmp blood kit (QIAGEN Inc.,
Valencia, CA, USA) after informed consent had been
obtained. Exon 4 of the APOE gene was amplified by
polymerase chain reaction (PCR) using the upstream
primer 5-TCGCGGGCCCCCGGGCCTGGTACA-3
and the downstream primer 5-ACAGAATTCGCCC-
CGGCCTGGTACACTGCCA-3. The PCR products
were digested with HhaI, and the fragments were
separated by electrophoresis on a 6% polyacrylamide
gel, followed by ethidium bromide staining. DNA
fragments were visualized under ultraviolet illumi-
nation. The APOE genotypes of patient and healthy
control groups were determined in a blinded fashion
by scoring for a unique combination of fragment sizes,
as described by Wenham et al [31].
Statistical analysis
A two-tailed Student’s t test was used to compare ages
and cholesterol levels between patients and the healthy
control group. Comparisons of lacunar patients and
atherothrombotic patients with controls were con-
ducted using the χ2 test on the frequencies of sex,
hypertension and diabetes mellitus (DM). The allele
frequencies in lacunar and atherothrombotic infarc-
tion patients and control subjects were estimated by
counting alleles and calculating sample proportions.
Comparisons of the genotype and allele frequencies
were made using a logistic regression model. The odds
ratios (ORs) were compared for the association of
APOE ε4 in the healthy controls (ε3/ε3) and lacunar
or atherothrombotic infarction patients.
RESULTS
The mean± standard deviation age was 64.3±7.9 years
for lacunar infarct patients, 63.0 ± 8.6 years for athero-
thrombotic patients, and 71.0 ± 10.6 years for healthy
controls. There were statistically significant differences
in age, with a preponderance of older ages in the con-
trols. The lacunar group consisted of 91 (63.6%) males
and 52 (36.4%) females. The atherothrombotic group
consisted of 73 (64.0%) males and 41 (36.0%) females,
and the control group was made up of 54 (48.2%)
males and 58 (51.4%) females. The lacunar and athero-
thrombotic groups showed a significant male pre-
dominance (Table 1).
As shown in Table 1, the frequencies of personal
histories of hypertension and DM were significantly
higher in lacunar and atherothrombotic infarct pa-
tients. There were no significant differences between
ischemic stroke patients and healthy controls in terms
of cholesterol level.
There was no significant difference in APOE geno-
type frequency between male and female subjects.
The APOE allelic frequencies of the lacunar patients
were as follows: ε2, 4.9%; ε3, 78.3%; ε4, 16.8%. In the
healthy control subjects, the data were as follows: ε2,
8.0%; ε3, 80.4%; ε4, 11.6%. The allele frequencies
among the three groups were not significantly differ-
ent (Table 2). However, comparison of the genotype
distribution, by logistic regression using ε3/ε3 as the
reference group, showed a statistically significant dif-
ference in the frequency of ε3/ε4 genotypes in patients
with lacunar infarcts (Table 2). Compared with healthy
control subjects, the OR of ε3/ε4 in lacunar patients
was 2.13 (95% confidence interval, 1.16–4.02; p=0.017).
The allelic frequencies of APOE in the athero-
thrombotic group were 6.6% for ε2, 80.7% for ε3 and
12.7% for ε4 (Table 2). No significant difference in the
ε4 or ε2 allele frequencies was noted between athero-
thrombotic patients and healthy control subjects. There
was also no significant difference between athero-
thrombotic patients and the control group in terms 
of genotype distribution, by logistic regression, using
ε3/ε3 as a reference group.
DISCUSSION
In the present study, the ε3/ε4 genotype frequencies
in lacunar patients were significantly higher than those
in healthy controls (30.8% vs. 16.9%). The odds of car-
rying a ε3/ε4 genotype in lacunar patients is twice
that in control subjects (OR, 2.13), by logistic regres-
sion using ε3/ε3 as a reference group. This finding
suggests that there may be a greater risk of lacunar
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Table 1. Clinical characteristics of Taiwan Chinese patients with ischemic cerebrovascular diseases and control 
subjects*
Lacunar patients Atherothrombotic patients Controls 
(n = 143) (n = 114) (n = 112)
Age (yr) 64.3 ± 7.9 63.0 ± 8.6 71.0 ± 10.6
Sex (M/F) 91/52 73/41 54/58
Hypertension 111 (77.6)† 93 (81.6)† 31 (27.7)
Diabetes mellitus 55 (38.5)† 47 (41.2)† 15 (13.4)
Cholesterol (mg/dL) 206.4 ± 45.0 199.8 ± 41.5 202.0 ± 33.8
*Data are presented as mean ± standard deviation or n (%); †p < 0.05 vs. control subjects, χ2 test.
Table 2. Distribution of apolipoprotein E genotypes and alleles in Taiwan Chinese patients with ischemic cerebrovas-
cular diseases and control subjects*
Lacunar patients Atherothrombotic Controls Lacunar patients vs. Atherothrombotic 
(n = 143) patients (n = 114) (n = 112) controls, p patients vs. controls, p
ε2 14 (4.9) 15 (6.6) 18 (8.0) 0.204 0.576
ε3 224 (78.3) 184 (80.7) 180 (80.4) – –
ε4 48 (16.8) 29 (12.7) 26 (11.6) 0.134 0.763
ε2/ε2 0 1 (0.9) 4 (3.6) – 0.224
ε2/ε3 10 (7.0) 7 (6.1) 5 (4.5) 0.287 0.565
ε2/ε4 4 (2.8) 6 (5.3) 5 (4.5) 0.654 0.755
ε3/ε3 85 (59.4) 77 (67.5) 78 (69.6) – –
ε3/ε4 44 (30.8) 23 (20.2) 19 (16.9) 0.017† 0.559
ε4/ε4 0 0 1 (0.9) – –
*Data are presented as n (%); †p < 0.05 vs. control subjects, logistic regression using ε3/ε3 as a reference group.
infarct in patients with the ε3/ε4 genotype. Previously,
the ε3/ε4 genotype has been associated with more
severe atherosclerosis [32] and may be related to the
development of carotid stenosis [19]. It is worth noting
that although lacunar infarcts are generally supposed
to be caused by hypertensive small-vessel disease
[12,33,34], other etiologies, including middle cerebral
artery atherosclerotic disease or hemodynamic com-
promise from a carotid lesion, have been postulated to
be related to lacunar infarcts [35]. In a study of healthy
families, it has been found that genetic factors may
strongly contribute to the intima-media thickness vari-
ability and that the APOE polymorphism may be one
of these factors [36]. Thus, it seems that lacunar
infarct may be related to a diversity of etiopathogenic
mechanisms, which may include the APOE polymor-
phism. However, it remains to be determined whether
genetic or environmental factors, or their interaction,
can explain the heterogeneity in lacunar infarction
risk in subjects with the ε3/ε4 genotype.
According to a previous report [3], deep cerebral
infarcts (lacunar infarct) were more common in Chinese
patients and are usually larger than those seen in pa-
tients from the West. This difference in lacunar pres-
entation could have been due to the effects of various
genetic factors. However, regarding the allele fre-
quency, although a higher prevalence of ε4 carriers in
lacunar patients has been described in some previous
studies [1,9,12,19], this is not the case in the present
study (16.8% vs. 11.6%, no significant difference). This
may have been due to the fact that ischemic stroke 
is a heterogeneous disease and the classification of
ischemic stroke into lacunar and atherothrombotic
subtypes with the exclusion of cardioembolic stroke
may have allowed differences to emerge [12].
On the other hand, atherosclerosis in larger arter-
ies has been related to high lipid levels and hyperten-
sion [1,37]. Because the APOE polymorphism plays 
a key role in plasma lipid level regulation [10], it is
assumed that APOE isoforms play an important role
in the pathogenesis of atherosclerosis [38]. However,
the present study demonstrates no significant differ-
ences in APOE ε4 or ε2 allele frequencies between
patients with atherothrombotic infarction and control
subjects, and the difference in genotype distribution
between the two groups is also insignificant (Table 2).
This suggests that the ε4 allele is not significantly
related to the development of atherothrombotic infarc-
tion and that the ε2 allele is not a significant factor in
preventing the development of atherothrombotic in-
farction, in line with some previous reports [14,16,17].
Therefore, the association of the APOE polymorphism
with atherothrombotic infarction remains controver-
sial, and other risk factors of atherothrombotic infarct
will be sought in the future.
Nonetheless, there are some significant points of
interest in the present study. First, although the present
study focused on the genetic risk factors for ischemic
stroke, some common stroke risk factors were also
evaluated and analyzed. It was shown that the fre-
quencies of personal histories of hypertension and DM
were significantly higher in lacunar and atherothrom-
botic infarct patients. These findings are consistent
with previous studies [6,7], which found that hyper-
tension and DM are risk factors for atherosclerosis. It is
interesting to note that although the role of apolipopro-
tein E polymorphism in the development of ischemic
infarcts in patients with DM has not been investi-
gated [39], the APOE ε4 allele has been found to be 
a susceptibility locus for systemic hypertension and
carotid artery atherosclerosis [40]. On the other hand,
there was no major association with cholesterol metab-
olism in stroke patients in the present study. Therefore,
the relationship between cholesterol metabolism and
stroke occurrence is still unclear. Second, some clini-
cal variables, such as the carotid status [41], incidences
of smoking and alcohol consumption [40], and his-
tory of previous transient ischemic attacks [42], were
not measured in the present study, and these factors
might confound the association of APOE polymor-
phism with ischemic stroke. Third, the relatively small
sample size limited the power to stratify coexisting
risk factors (such as hypertension and DM) in both
lacunar and atherothrombotic infarction. The associ-
ations between the APOE polymorphism and hyper-
tension, DM or cholesterol level in ischemic stroke
patients need further epidemiologic studies.
In conclusion, the present study of Taiwan Chinese
stroke patients demonstrates a probable association
between ε3/ε4 genotype and lacunar infarction, but
not between APOE genotype or allele frequency and
atherothrombotic infarction. Although the pathogen-
esis of lacunar infarction remains unclear, the present
study suggests that genetic factors may play a role, at
least partially, in the occurrence of lacunar infarction.
Further studies are necessary to clarify the confound-
ing factors in ischemic stroke, such as hypertension
and DM.
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